The NADPH-dependent nitrile-oxidioreductase, QueF is the only known enzyme capable of reducing a nitrile group to an amine. This ability makes it an attractive alternative to conventional industrial nitrile redution. Understating how QueF binds NADPH may lead to the development of an enzyme capable of using the less expensive reductive cofactor NADH. A cofactor docking model indicates that key residues, Q60 and Y21, interact with the ribose phosphate moiety unique to NADPH. Mutants of these residues (Q60A, Q60N, Q60E, Y21A and Y21F) were developed for steady-state kinetic analysis. Modification to either residue resulted in a decrease in binding and catalytic activity when using NADPH as a hydride source. Q60E had the greatest reduction in activity (0.45% of WT). There appears to be both charge and steric factors involved in direct cofactor binding. Neither WT or mutant enzymes were able to utilize NADH as a reductive cofactor to any observable extent.
Abstract
The NADPH-dependent nitrile-oxidioreductase, QueF is the only known enzyme capable of reducing a nitrile group to an amine. This ability makes it an attractive alternative to conventional industrial nitrile redution. Understating how QueF binds NADPH may lead to the development of an enzyme capable of using the less expensive reductive cofactor NADH. A cofactor docking model indicates that key residues, Q60 and Y21, interact with the ribose phosphate moiety unique to NADPH. Mutants of these residues (Q60A, Q60N, Q60E, Y21A and Y21F) were developed for steady-state kinetic analysis. Modification to either residue resulted in a decrease in binding and catalytic activity when using NADPH as a hydride source. Q60E had the greatest reduction in activity (0.45% of WT). There appears to be both charge and steric factors involved in direct cofactor binding. Neither WT or mutant enzymes were able to utilize NADH as a reductive cofactor to any observable extent.
Background
Transfer ribonucleic acids (tRNAs) are the adaptor molecules that allow for accurate translation of messenger RNA (mRNA) to peptide. tRNA effectively translates genetic information to peptide by matching the correct amino acid to the genetic information carried by the mRNA in the ribosome 1 found in tRNAs with the GUN anticodon consensus sequence (tRNA asp , tRNA asn , tRNA his , tRNA tyr ) and serves as a structurally constraining base for tRNA codon loop flexibility. Queuosine is an essential micronutrient obtained by eukaryotes from diet or gut bacteria 5, 6 .
QueF
The first portion of the queusoine biosynthetic pathway begins with the medication of guanosine triphosphate (GTP) to 7-cyano-7-deazaguanine (PreQ 0 ). 7-cyano-7-deazaguanine reductase (QueF) member of the Tunneling-fold (T-fold) super family. T-fold proteins bind substrates belonging to purine and pterin families. Their monomers consist of two alpha helicies layered onto the concave side of a four strand antiparallel beta sheet. Multiple monomers come together to form a barrel and two barrels combine head on to form the final multimeric tunnel 9 . The number of individual domains varies within the T-fold family, and size exclusion studies and X-ray crystal structures have shown QueF to be a homodecamer 10, 8 . 
Application
Conventional industrial nitrile reduction involves hydrogenation over a metal catalyst or by metal hydride reduction 11, 12 . Enzymes have the ability to operate in an aqueous environment at physiological temperature and pressure. To satisfy increasing green chemistry standards, the demand for biocatalysts in product synthesis, extraction, purification and waste treatment is increasing 13 . Relaxing cofactor specificity is important to the use of QueF as a biocatalyst. NADPH and NADH are identical molecules aside from the presence of a phosphate group at the 2' position of the ribose ring that carries the adenine moiety in NADPH. NADPH costs over $10,000/mmol where as NADH costs near $380/mmol (Sigma 2015).
This high cofactor price can be further reduced by developing NADH regenerative systems to be used in parallel with the catalyst 14 .
Methods for engineering an enzyme for industrial use typically include directed evolution, rational design or a combination of the two 15 . Directed evolution mimics the process of evolution by introducing mutations and selecting variants with the desired function by application of a selective pressure. This method can be performed in vivo and in vitro. Rational design involves logically altering the structure of a protein through the site specific change in identity of target amino acid residues in order to alter the characteristics of the enzyme. Rational design was the method chosen for altering cofactor specificity in this project.
Experimental Design
Analysis of QueF cofactor docking models suggests an asymmetrical interaction between the decamer and NADPH ( Figure 4 ). This interaction is comprised of the cofactor binding in the crease formed by three of the ten subunits, the nicotinamide group of NADPH positioned near the active site. Residues Q60 and Y21 appear to play an integral role in NADPH specificity. Q60 and Y21 of one subunit appear to interact with the 2'-phosphate of NADPH while the same residues of an adjacent subunit appear to interact with the 2'-hydroxyl of the nicotinamide ribose. This presents a unique challenge in rational design, as where it would be advantageous to alter the interaction at the site of the phosphate, a change here may also alter interaction at the ribose. Site directed mutagenesis and subsequent steady state kinetic analysis will be utilized to determine the residue's function in relation to cofactor binding and specificity. Q60 and Y21
will be mutated to alanine residues to establish their importance in cofactor binding. The residues will then be changed to amino acids with slightly different steric and electronic qualities (Q60A, Q60E, Q60N, Y21A, Y21F). Altering the sequence of amino acids within a protein can have a number of effects on its structure. The mutation can cause the protein to miss-fold, distorting the global structure of the monomer. This distortion can cause the protein to aggregate or prevent the mutant from otherwise forming the homodecamer, rendering it incapable of performing catalysis. Mutations may also distort the substrate binding pocket which can either affect substrate binding or the subsequent thioimide formation. Finally, the mutation can distort the cofactor binding pocket and alter cofactor binding or specificity.
To insure each mutant can still form a homodecamer their ability to bind substrate and form thioimide was assessed. The ability to form a thioimide bond with substrate can be used to confirm that the quaternary structure is intact as the active site is comprised of four monomers, two from each barrel.
Inability to form thioimide indicates either the substrate binding pocket has been disrupted or the monomers cannot assemble to form the homodecamer. Steady state kinetics analysis was used to determine the effect of the mutation on the the enzymes ability to bind the cofactor as well as its ability to perform the necessary chemistry to carryout the reaction. In addition to NADPH turnover assays, all mutants were subject to NADH turnover assays to determine if substrate specificity had been altered by the mutation.
Methods and Materials

General
Olgionucleotide synthesis was carried out by Integrated DNA Technologies, and sequencing was conducted by the Core Sequence Facility of Oregon Health and Science University. Protein concentrations were determined by UV-Vis spectroscopy on a Cary 100 Bio UV-Visible spectrophotometer, extinction coefficients were generated with Expasy ProtParam and confirmed by Bradford assay 16, 17 .
Growth conditions
Cell cultures were grown at 37°C in LB with kanamycin (50ug/ml).
Mutagenesis-Transformation
Site-directed mutagenesis was conducted using the Quick Change Mutagenesis Kit II (Agilent Technologies) 18 . Plasmids were transformed into NovaBlue (Novagen) competent cell for plasmid production, confirmed by Sanger sequencing and transformed into BL21 (Novagen) competent cells for protein over-production. Post induction cells were harvested by centrifugation (10000g for 20 mins) and resuspended in purification buffer (100 mM Tris-HCl pH 8.0, 100 mM KCl, 2 mM ß-mercaptoethanol) supplemented with with 1mM PMSF and 250 µg/mL lysozyme to a final concentration of 250 g/mL. The resulting solutions were centrifuged (20Kg x 20min) and the supernatant applied to prequilibrated 5ml Ni-NTA (Qiagen)
columns. Once loaded, the column was washed with 10CV purification buffer + 1 mM PMSF, 10CV purification buffer +20 mM imidazole, and the protein was eluted with 5CV purification buffer +200 mM imidizole. The protein was concentrated and the imidazole was removed from the elution fraction by dialysis (SnakeSkin dialysis tubing) against purification buffer, and stored at -80°C. Glycerol was added to 50% of the purified protein.
Turnover assays and relative activity
Consumption of NADPH was measured by loss of absorbance at 340 nm (ε=6220 M -1 cm -1 ). Reaction was carried out at 37°C in 100 mM potassium phosphate (pH 6.5), 50 mM KCl, 20 mM MgCl 2 and 1 mM DTT.
Wild type (WT) (200 nM) and mutant enzymes (20 µM) were incubated with 100 µM PreQ 0 for two minutes. Reaction was initiated with 180 µM NADPH and monitored for 10 minutes.
Thioimide formation
The thioimide bond forms a unique chromophore centered at 376 nm. Reaction mixtures were scanned between 230 and 420 nm to determine the extent of bond formation. Assay conditions were 100 mM phosphate (pH 6.5), 50mM KCl, 20 mM MgCl 2 and 1mM DTT. Enzyme at 20 µM was saturated with 100 µM PreQ 0 .
NADH turnover assays
Consumption of NADH was measured by loss of absorbance at 340 nm (ε=6220 M -1 cm -1 ). Reaction was carried out at 37°C in 100 mM potassium phosphate (ph 6.5), 50 mM KCL, 20 mM MgCl 2 and 1 mM DTT.
Wild type (WT) (200 nM) and mutant enzyme (20 µM) were incubated with 100 µM PreQ 0 for two minutes.
Reaction was initiated with 180 µM NADH and monitored for 10 minutes. 
Steady-state kinetic analysis -NADPH
Equation 1
Results Figure 5 Thioimide formation of WT and mutant QueF T21F, Q60N, Q60E and WT were able to form a thioimide bond (376 nm) with PreQ 0 . C55A, lacking the nucleophilic cysteine residue was unable to form thioimide and was used as a control. Under saturating conditions of PreQ 0 , working with in the limits of the NADPH assay and an enzyme increase 12.5 fold, neither WT or mutant enzymes showed any reductive activity under the presence of NADH. The NADH oxidation rates for each enzyme are available in Table 2 . Despite not having discrete on and off rates we can use the Km to approximate the Kd. The k cat was determined using Equation 2. Q60A Km is 5.7 times WT and has a k cat 59% of WT, indicating a decrease in cofactor affinity and reduction in the rate of catalysis. Q60N Km is 1.95 times WT and has a k cat 26% of WT, indicating an affinity for cofactor greater than Q60A but less than that of WT and a rate of catalysis lower than Q60A and WT. Q60E activity was too low to yield any kinetic data from this experiment.
However, under enzyme concentrations 62.5 times higher (25 µM) a rate 4 times slower that WT was observed yielding a 250-fold decrease in activity. Y21A Km is 3.06 times WT and has k cat 57% of WT indicating a decrease in cofactor affinity and reduciton in the rate of catalysis. Y21F Km is 1.39 times WT and has k cat 54% of WT, indicating a lesser reduction of affinity for cofactor than in Y21A and a similar decreased rate of catalysis.
Discussion
NADH turnover assay
No mutants were able to utilize NADH as a cofactor for PreQ0 reduction. This is in contrast to the hypothesis that residues Q60 and Y21 played a specific, distinct role in cofactor specificity. The inability of neither WT or mutant QueF may implicate that these residues interact with the phosphate moiety to stabilize and position NADPH to allow for proper hydride transfer.
Steady state kinetic analysis
The k cat can be used to represent the catalytic velocity of the enzyme under ideal, saturated conditions.
Individual on and off rates ( Figure 7 ) cannot be determined using steady-state kinetic analysis. Despite not having discrete on and off rates we can use the Km to approximate the Kd. The Kd being the ratio of the on and off rates of the ES complex, in this case the ES+NADPH complex. The lower the Kd, here the Km, the higher the enzyme's affinity for the substrate. The ratio of k cat /Km is a measure of catalytic efficiency, a fast enzyme and or one that can bind substrate at low concentrations will be a more efficient enzyme and will there have a larger ratio of k cat /Km. Although the docking model shows targeted residues do not directly interact with PreQ0 binding, without steady-state kinetic analysis of PreQ 0 binding we cannot claim that the mutated residues do not have any concurrent effect on PreQ 0 interaction.
Figure 8 QueF kinetic scheme
At the time of discovery, initial characterization determined the WT Km for NADPH to be 36µM and the k cat to be 0.6 min -1 (100mM Hepes pH 7.5, 1 mM DTT, 50-100 mM KCl at 30°C). 19 A second characterization of WT after metal binding studies showed the Km and V max to be 19.2±1.07 µM and 0.69±0.02 min -1 , respectively (100 mM TRIS pH 7.5, 100 mM KCl, 1mM DTT 20 µM PreQ 0 , 0.776 µM WT QueF for 120s at 30°C) 7 . Both assessments used the continuous UV-vis assay employed in this experiment. The disparity between the rates achieved in this experiment, Km: 58.21±10.87 µM and k cat : 1.89±0.38 min -1 , compared to those of past papers can be attributed to the different conditions, mainly the pH of the reaction buffer.
Studies following the first two characterizations and preceding this experiment determined optimal enzyme activity proceeded at pH 6.5.
Q60A, having essentially all steric and electric influence eliminated had a much larger Km, nearly 6X of WT and it's k cat was 59% of WT. This is supports the relationship posed by the docking model that Q60 has a role in coordinating cofactor binding/positioning. The decrease in k cat may be a product of diminished ability to position the substrate by interaction with the 2'OH of the ribose on the subunit proximal to the active site.
The Q60N mutant would draw the amide side-chain towards the protein backbone. Consistent with the hypothesis, the Km was greater than WT but less than Q60A, indicating an affinity for cofactor somewhere in between WT and the alanine mutant. Interestingly, the k cat , at 26% of WT, was lower than that of the alanine mutant. This may indicate that Q60 may play an important role in positioning the NAPDH appropriately for hydride transfer. If the R-group of glutamine acts as a positive cup to cradle the negatively charged phosphate, then the shorter R-group of asparagine may position the nicotinamide moiety unfavorable, thereby preserving the affinity for substrate yet reducing the overall catalytic rate.
The Q60E mutant may be the most important in supporting the hypothesis that Q60 interacts with the cofactor phosphate. With 250X less activity than wild type its kinetic parameters were unable to be experimentally derived. Such a reduction in activity may be attributed to the change in the side chain function group from an amide to a carboxylate. This strong negative charge of the side chain and the negative charge of the phosphate group would likely repulse each other, making docking of the cofactor unfavorable and thereby nearly eliminating its ability to bind cofactor and perform catalysis. Thioimide forming studies eliminate the possibility that the Q60E mutation impacted the global structure of the enzyme since PreQ 0 binding is essentially unperturbed.
The kinetic data for Y21A and Y21F supported the hypothesis that they have some affect on cofactor docking and binding. The greater the deviation from the tyrosine side-chain structure the higher the Km, possibly revealing the steric importance of Y21 in binding/docking NADPH. The k cat of the alanine and phenylalanine mutants were similar at 54% and 57% of WT, respectively. This decrease in k cat may be due to decreased unfavorable positioning of the substrate.
This data provides in vitro support that Q60 and Y21 effect cofactor binding, if not in cofactor scpecifcity 
